LMPTP INHIBITOR 1 dihydrochloride
98%
- Product Code: 108750
CAS:
2310135-46-5
| Molecular Weight: | 517.53 g./mol | Molecular Formula: | C₂₈H₃₈Cl₂N₄O |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
LMPTP Inhibitor 1 dihydrochloride is primarily utilized in biomedical research to study and target low molecular weight protein tyrosine phosphatase (LMPTP). Its application is significant in understanding cellular signaling pathways, particularly those involved in metabolic regulation and insulin signaling. Researchers use this inhibitor to explore potential therapeutic strategies for metabolic disorders, such as type 2 diabetes, by modulating LMPTP activity. Additionally, it aids in investigating the role of LMPTP in other diseases where tyrosine phosphorylation plays a critical role, including cancer and cardiovascular conditions. Its use in preclinical studies helps in evaluating the efficacy and safety of targeting LMPTP for drug development.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | Solid |
| Purity (%) | 97.5-100 |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | $2,761.93 |
+
-
|
LMPTP INHIBITOR 1 dihydrochloride
LMPTP Inhibitor 1 dihydrochloride is primarily utilized in biomedical research to study and target low molecular weight protein tyrosine phosphatase (LMPTP). Its application is significant in understanding cellular signaling pathways, particularly those involved in metabolic regulation and insulin signaling. Researchers use this inhibitor to explore potential therapeutic strategies for metabolic disorders, such as type 2 diabetes, by modulating LMPTP activity. Additionally, it aids in investigating the role of LMPTP in other diseases where tyrosine phosphorylation plays a critical role, including cancer and cardiovascular conditions. Its use in preclinical studies helps in evaluating the efficacy and safety of targeting LMPTP for drug development.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :